Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures

被引：268
作者：
Gamelin, E
Gamelin, L
Bossi, L
Quasthoff, S
机构：
[1] Ctr Paul Papin, F-49033 Angers, France
[2] Karl Franzens Univ Graz, Dept Neurol, Graz, Austria
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 05期
关键词：
D O I：
10.1053/sonc.2002.35525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 33
页数：13
相关论文
共 71 条
[1]   The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons [J].
Adelsberger, H ;
Quasthoff, S ;
Grosskreutz, J ;
Lepier, A ;
Eckel, F ;
Lersch, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (01) :25-32
[2]   Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen [J].
André, T ;
Bensmaine, MA ;
Louvet, C ;
François, E ;
Lucas, V ;
Desseigne, F ;
Beerblock, K ;
Bouché, O ;
Carola, E ;
Merrouche, Y ;
Morvan, F ;
Dupon-André, G ;
de Gramont, A .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3560-3568
[3]   Calcium block of Na+ channels and its effect on closing rate [J].
Armstrong, CM ;
Cota, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :4154-4157
[4]   Ion channel mutations and diseases of skeletal muscle [J].
Barchi, RL .
NEUROBIOLOGY OF DISEASE, 1997, 4 (3-4) :254-264
[5]   The use of anticonvulsants in neurological conditions other than epilepsy - A review of the evidence from randomised controlled trials [J].
Beghi, E .
CNS DRUGS, 1999, 11 (01) :61-82
[6]  
Boughattas N., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P433
[7]   EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1 [J].
BROWNE, DL ;
GANCHER, ST ;
NUTT, JG ;
BRUNT, ERP ;
SMITH, EA ;
KRAMER, P ;
LITT, M .
NATURE GENETICS, 1994, 8 (02) :136-140
[8]   CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE [J].
CANETTA, R ;
ROZENCWEIG, M ;
CARTER, SK .
CANCER TREATMENT REVIEWS, 1985, 12 :125-136
[9]  
Cavaletti G, 2000, CLIN CANCER RES, V6, p4537S
[10]  
Cavaletti G, 1998, ANTICANCER RES, V18, P3797
12345678